Acadia Healthcare Co. (NASDAQ:ACHC)’s share price traded down 5.4% during trading on Thursday . The stock traded as low as $50.91 and last traded at $53.40, with a volume of 2,912,317 shares changing hands. The stock had previously closed at $56.43.

Several equities analysts have commented on the company. Cantor Fitzgerald reaffirmed a “buy” rating on shares of Acadia Healthcare in a research report on Friday, April 29th. Leerink Swann reiterated an “outperform” rating and issued a $90.00 target price on shares of Acadia Healthcare in a report on Friday. Zacks Investment Research upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and set a $71.00 target price for the company in a report on Monday, May 2nd. Jefferies Group reiterated a “buy” rating and issued a $85.00 target price on shares of Acadia Healthcare in a report on Thursday, May 5th. Finally, Robert W. Baird reiterated an “outperform” rating and issued a $69.00 target price on shares of Acadia Healthcare in a report on Tuesday, June 14th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have given a buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $79.33.

The firm’s 50-day moving average price is $57.51 and its 200 day moving average price is $57.64. The stock has a market cap of $4.65 billion and a price-to-earnings ratio of 31.60.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Thursday, April 28th. The company reported $0.55 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.54 by $0.01. During the same period in the previous year, the firm posted $0.43 earnings per share. The firm earned $616.80 million during the quarter, compared to analyst estimates of $612.77 million. The company’s quarterly revenue was up 68.6% compared to the same quarter last year. On average, equities research analysts anticipate that Acadia Healthcare Co. will post $2.83 EPS for the current fiscal year.

Several large investors have recently modified their holdings of the stock. State Board of Administration of Florida Retirement System boosted its stake in shares of Acadia Healthcare by 8.5% in the fourth quarter. State Board of Administration of Florida Retirement System now owns 33,247 shares of the company’s stock worth $2,077,000 after buying an additional 2,596 shares during the last quarter. Rhumbline Advisers boosted its stake in shares of Acadia Healthcare by 6.1% in the fourth quarter. Rhumbline Advisers now owns 53,198 shares of the company’s stock worth $3,323,000 after buying an additional 3,045 shares during the last quarter. California Public Employees Retirement System boosted its stake in shares of Acadia Healthcare by 0.9% in the fourth quarter. California Public Employees Retirement System now owns 82,700 shares of the company’s stock worth $5,165,000 after buying an additional 700 shares during the last quarter. New York State Common Retirement Fund boosted its stake in shares of Acadia Healthcare by 11.3% in the fourth quarter. New York State Common Retirement Fund now owns 190,543 shares of the company’s stock worth $11,901,000 after buying an additional 19,337 shares during the last quarter. Finally, BOKF NA boosted its stake in shares of Acadia Healthcare by 21.3% in the fourth quarter. BOKF NA now owns 49,771 shares of the company’s stock worth $3,109,000 after buying an additional 8,752 shares during the last quarter.

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The Company develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.